125 related articles for article (PubMed ID: 15882401)
1. p53 expression in canine lymphoma.
Sokołowska J; Cywińska A; Malicka E
J Vet Med A Physiol Pathol Clin Med; 2005 May; 52(4):172-5. PubMed ID: 15882401
[TBL] [Abstract][Full Text] [Related]
2. Mutations of the p53 gene in canine lymphoma and evidence for germ line p53 mutations in the dog.
Veldhoen N; Stewart J; Brown R; Milner J
Oncogene; 1998 Jan; 16(2):249-55. PubMed ID: 9464543
[TBL] [Abstract][Full Text] [Related]
3. p53 protein expression does not correlate with EBV status in childhood B non-Hodgkin lymphomas.
Klumb CE; Hassan R; Zalcberg IR; Resende LM; Carriço MK; Maia RC
Pediatr Blood Cancer; 2004 Aug; 43(2):115-9. PubMed ID: 15236276
[TBL] [Abstract][Full Text] [Related]
4. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of protein p53 in neoplasms of the mammary gland in bitches.
Rodo A; Malicka E
Pol J Vet Sci; 2008; 11(2):89-95. PubMed ID: 18683536
[TBL] [Abstract][Full Text] [Related]
6. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
Lee CH; Kweon OK
J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
[TBL] [Abstract][Full Text] [Related]
7. Mutation of p53 Gene and Its Correlation with the Clinical Outcome in Dogs with Lymphoma.
Koshino A; Goto-Koshino Y; Setoguchi A; Ohno K; Tsujimoto H
J Vet Intern Med; 2016; 30(1):223-9. PubMed ID: 26678182
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of p63 and deltaNp63 in mixed tumors of canine mammary glands and its relation with p53 expression.
Bertagnolli AC; Cassali GD; Genelhu MC; Costa FA; Oliveira JF; Gonçalves PB
Vet Pathol; 2009 May; 46(3):407-15. PubMed ID: 19176510
[TBL] [Abstract][Full Text] [Related]
9. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
10. Identification of tumour-associated and germ line p53 mutations in canine mammary cancer.
Veldhoen N; Watterson J; Brash M; Milner J
Br J Cancer; 1999 Oct; 81(3):409-15. PubMed ID: 10507764
[TBL] [Abstract][Full Text] [Related]
11. The immunohistochemical and serological determination of p53 protein in patients with malignant lymphomas.
Jezersek-Novaković B; Frković-Grazio S; Novaković S
Neoplasma; 2002; 49(1):16-20. PubMed ID: 12044054
[TBL] [Abstract][Full Text] [Related]
12. Canine lymphomas: a morphological and immunohistochemical study of 55 cases, with observations on p53 immunoexpression.
Sueiro FA; Alessi AC; Vassallo J
J Comp Pathol; 2004; 131(2-3):207-13. PubMed ID: 15276860
[TBL] [Abstract][Full Text] [Related]
13. TSLC1 tumour-suppressor gene expression in canine mast cell tumours.
Taylor F; Murphy S; Hoather T; Dobson J; Scase T
Vet Comp Oncol; 2010 Dec; 8(4):263-72. PubMed ID: 21062408
[TBL] [Abstract][Full Text] [Related]
14. Expression of the high mobility group A1 (HMGA1) and A2 (HMGA2) genes in canine lymphoma: analysis of 23 cases and comparison to control cases.
Joetzke AE; Sterenczak KA; Eberle N; Wagner S; Soller JT; Nolte I; Bullerdiek J; Murua Escobar H; Simon D
Vet Comp Oncol; 2010 Jun; 8(2):87-95. PubMed ID: 20579321
[TBL] [Abstract][Full Text] [Related]
15. Microvessel density in normal lymph nodes and lymphomas of dogs and their correlation with vascular endothelial growth factor expression.
Wolfesberger B; Tonar Z; Witter K; Guija de Arespacohaga A; Skalicky M; Walter I; Thalhammer JG; Egger GF
Res Vet Sci; 2008 Aug; 85(1):56-61. PubMed ID: 17888471
[TBL] [Abstract][Full Text] [Related]
16. Using lymph node fine needle aspirates for gene expression profiling of canine lymphoma.
Starkey MP; Murphy S
Vet Comp Oncol; 2010 Mar; 8(1):56-71. PubMed ID: 20230582
[TBL] [Abstract][Full Text] [Related]
17. GeneScanning analysis of Ig/TCR gene rearrangements to detect clonality in canine lymphomas.
Gentilini F; Calzolari C; Turba ME; Bettini G; Famigli-Bergamini P
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):47-56. PubMed ID: 18963006
[TBL] [Abstract][Full Text] [Related]
18. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
[TBL] [Abstract][Full Text] [Related]
19. Sequence analysis of canine LINE-1 elements and p53 gene in canine transmissible venereal tumor.
Choi YK; Kim CJ
J Vet Sci; 2002 Dec; 3(4):285-92. PubMed ID: 12825561
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism of P53-Ets/AP1 transactivation region of MDM2 oncogene and its immunohistochemical analysis in canine tumours.
Rezaie A; Tabandeh MR; Noori SM
Vet Comp Oncol; 2016 Jun; 14(2):137-46. PubMed ID: 24447820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
